Lung Cancer Research Network
The Network, made up of over 20 research teams, forms a multidisciplinary group of basic and applied researchers and clinicians, with more to join as the centre expands.
At this one-of-a kind facility, researchers can share results and innovate faster, advancing the field of lung cancer diagnosis and treatment as has never been seen before.
The Lung Cancer Research Networks priority goal is to develop innovative solutions that will improve the healthcare outcomes and quality of life for people suffering with lung cancer. As part of this goal the Network has identified a number of streams or 'Core Translation Projects'. These projects leverage the large Network of basic scientists and healthcare professionals working in the area of lung cancer and are broadly split into early diagnosis, therapy, improving quality of life and improving clinical care. These project are classified as translational since we will rapidly translate findings and new discoveries to the clinic, to make a positive impact for those diagnosed with lung cancer.
Core translational projects:
Non-invasive early diagnosis
The Network’s founding research teams have a proven track record in research and clinical excellence.
- They see 7,000 respiratory and cancer patients a year
- They have published 2,200 peer-reviewed journal articles between them
- Their research across cancer biology, drug discovery, drug delivery clinical management and treatment has attracted more than $120 million in grant income over the past five years
- They have graduated more than 130 higher degree research students in the same period
With this experience and reach, they’re perfectly placed to engage with patients, funders and industry and fuel desperately-needed growth in lung cancer research.
THE BIG PICTURE
The Network links researchers with clinicians and health care providers across five core areas: patient interface, mechanism of disease, drug discovery, modelling disease/drug evaluation, and drug delivery and technology.
This unique approach allows for a truly translational path to treating lung cancer, since each arm can provide scientific input, material and knowledge that support research in the other arms.
Excitingly, this collaborative environment allows for an almost unlimited number of ‘multi- disciplinary’ projects.